Patent · US Expired

1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases

US7235551B2 · kind B2 · utility

11Cited by
57References
104Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 2, 2001
Grant dateJun 26, 2007
Priority date—
Expiry dateMar 2, 2021

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel substituted pyrimidol[4,5-d]pyrimidin-2-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.